Rocket Pharmaceuticals, Inc. (RCKT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Rocket Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.75x | -4.61x | -10.25x | -6.01x | -8.16x | -20.71x |
| P/B Ratio | 1.41x | 2.57x | 5.11x | 2.72x | 3.04x | 6.03x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.38x | 9.30x | 7.80x | 9.29x | 17.69x | 14.94x |
| Quick Ratio | 6.38x | 9.30x | 7.80x | 9.29x | 17.69x | 14.94x |
| Leverage | ||||||
| Debt/Equity | 0.09x | 0.06x | 0.05x | 0.05x | 0.05x | 0.12x |
YoY = year-over-year change. Source: FMP..